ACUTAAS CHEMICALS Financial Statement Analysis
|
||
|
The Revenues of ACUTAAS CHEMICALS have increased by 40.34% YoY .
The Earnings Per Share (EPS) of ACUTAAS CHEMICALS has increased by 124.39 % YoY. |
||
ACUTAAS CHEMICALS Last 5 Annual Financial Results
[BOM: 543349|NSE : ACUTAAS]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹1,007 Cr | ₹717 Cr | ₹617 Cr | ₹520 Cr | ₹341 Cr |
| Expenses | ₹775 Cr | ₹589 Cr | ₹494 Cr | ₹415 Cr | ₹260 Cr |
| Operating Profit (Excl OI) | ₹232 Cr | ₹128 Cr | ₹123 Cr | ₹105 Cr | ₹80 Cr |
| Other Income | ₹17 Cr | ₹7.49 Cr | ₹4.32 Cr | ₹2.76 Cr | ₹1.38 Cr |
| Interest | ₹6.22 Cr | ₹5.94 Cr | ₹2.41 Cr | ₹6.41 Cr | ₹5.62 Cr |
| Depreciation | ₹27 Cr | ₹16 Cr | ₹12 Cr | ₹10 Cr | ₹4.19 Cr |
| Profit Before Tax | ₹216 Cr | ₹82 Cr | ₹112 Cr | ₹91 Cr | ₹72 Cr |
| Profit After Tax | ₹160 Cr | ₹49 Cr | ₹83 Cr | ₹72 Cr | ₹54 Cr |
| Consolidated Net Profit | ₹159 Cr | ₹43 Cr | ₹83 Cr | ₹72 Cr | ₹54 Cr |
| Earnings Per Share (Rs) | ₹43.51 | ₹19.39 | ₹11.60 | ₹22.86 | ₹19.75 |
| PAT Margin (%) | 26.61 | 15.93 | 6.79 | 13.50 | 13.83 |
| ROE(%) | 24.08 | 16.19 | 7.70 | 14.92 | 21.07 |
| ROCE(%) | 32.42 | 20.14 | 11.81 | 20.45 | 23.85 |
| Total Debt/Equity(x) | 0.02 | 0.01 | 0.32 | 0.01 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 32,114.2 Cr |
| Revenue (TTM) | : | ₹ 1,592.5 Cr |
| Net Profit(TTM) | : | ₹ 438.6 Cr |
| EPS (TTM) | : | ₹ 53.6 |
| P/E (TTM) | : | 73.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ACUTAAS CHEMICALS | 4.1% | 24.8% | 119.1% |
| SUN PHARMACEUTICAL INDUSTRIES | 3.9% | 7.8% | 13% |
| DIVIS LABORATORIES | 11.5% | 20.6% | 68% |
| TORRENT PHARMACEUTICALS | 1% | 1.8% | 34.3% |
| CIPLA | 1.1% | 7.9% | -6.3% |
| DR REDDYS LABORATORIES | 1.1% | 11.8% | 14.9% |
| MANKIND PHARMA | 5.7% | 10.8% | 15.2% |
| LUPIN | 1.7% | 3.9% | 2.9% |
| ZYDUS LIFESCIENCES | -0.5% | 4.5% | 29.6% |
ACUTAAS CHEMICALS Revenues
[BOM: 543349|NSE : ACUTAAS]
| Y-o-Y | 40.34 % |
| 5 Yr CAGR | 31.12 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,007 Cr | 40.34 | |
| Mar2025 | ₹717 Cr | 16.33 | |
| Mar2024 | ₹617 Cr | 18.57 | |
| Mar2023 | ₹520 Cr | 52.71 | |
| Mar2022 | ₹341 Cr | - | |
ACUTAAS CHEMICALS Operating Profit
[BOM: 543349|NSE : ACUTAAS]
| Y-o-Y | 80.62 % |
| 5 Yr CAGR | 30.44 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹232 Cr | 80.62 | |
| Mar2025 | ₹128 Cr | 4.80 | |
| Mar2024 | ₹123 Cr | 16.57 | |
| Mar2023 | ₹105 Cr | 31.22 | |
| Mar2022 | ₹80 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 28.70 % |
| 5 Yr CAGR | -0.51 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 23.05% | 28.70 | |
| Mar2025 | 17.91% | -9.91 | |
| Mar2024 | 19.88% | -1.68 | |
| Mar2023 | 20.22% | -14.07 | |
| Mar2022 | 23.53% | - | |
ACUTAAS CHEMICALS Profit After Tax
[BOM: 543349|NSE : ACUTAAS]
| Y-o-Y | 271.06 % |
| 5 Yr CAGR | 30.94 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹159 Cr | 271.06 | |
| Mar2025 | ₹43 Cr | -48.65 | |
| Mar2024 | ₹83 Cr | 15.77 | |
| Mar2023 | ₹72 Cr | 33.24 | |
| Mar2022 | ₹54 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 67.04 % |
| 5 Yr CAGR | 17.78 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 26.61 % | 67.04 | |
| Mar2025 | 15.93 % | 134.61 | |
| Mar2024 | 6.79 % | -49.70 | |
| Mar2023 | 13.5 % | -2.39 | |
| Mar2022 | 13.83 % | - | |
ACUTAAS CHEMICALS Earnings Per Share (EPS)
[BOM: 543349|NSE : ACUTAAS]
| Y-o-Y | 124.39 % |
| 5 Yr CAGR | 21.83 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹44 | 124.39 | |
| Mar2025 | ₹19 | 67.16 | |
| Mar2024 | ₹12 | -49.26 | |
| Mar2023 | ₹23 | 15.75 | |
| Mar2022 | ₹20 | - | |
ACUTAAS CHEMICALS Return on Capital Employed (ROCE)
[BOM: 543349|NSE : ACUTAAS]
| Y-o-Y | 60.97 % |
| 5 Yr CAGR | 7.98 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 32.42% | 60.97 | |
| Mar2025 | 20.14% | 70.53 | |
| Mar2024 | 11.81% | -42.25 | |
| Mar2023 | 20.45% | -14.26 | |
| Mar2022 | 23.85% | - | |
ACUTAAS CHEMICALS Share Price vs Sensex
| Current Share Price | : | ₹3,921.2 |
| Current MarketCap | : | ₹ 32,114.2 Cr |
| Updated EOD on | : | Nov 11,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ACUTAAS CHEMICALS | 4.1% |
24.8% |
119.1% |
| SENSEX | 5.9% |
13% |
-1.9% |
ACUTAAS CHEMICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 500 | 4.5% | 8.8% | 0.2% |
| BSE 1000 | 4.3% | 8.1% | 0.6% |
| BSE HEALTHCARE | 3.7% | 8.5% | 18.1% |
| BSE 500 MOMENTUM 50 | 3.3% | 4.8% | 5.2% |
| BSE 400 MIDSMALLCAP INDEX | 3.1% | 3.6% | 1.2% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 500 | 4.4% | 8.8% | 0.4% |
| NIFTY TOTAL MARKET | 4.4% | 8.4% | 0.8% |
| NIFTY500 MULTICAP INDIA MANUFACTURING 50:30:20 | 4.1% | 9.4% | 7% |
| NIFTY500 HEALTHCARE INDEX | 3.8% | 9.4% | 18.4% |
| NIFTY MIDSMALL HEALTHCARE | 3.6% | 8.5% | 22.4% |
You may also like the below Video Courses
FAQ about ACUTAAS CHEMICALS Financials
How the annual revenues of ACUTAAS CHEMICALS have changed ?
The Revenues of ACUTAAS CHEMICALS have increased by 40.34% YoY .
How the Earnings per Share (EPS) of ACUTAAS CHEMICALS have changed?
The Earnings Per Share (EPS) of ACUTAAS CHEMICALS has increased by 124.39 % YoY .
Check out Intrinsic Value of Peers of ACUTAAS CHEMICALS
Compare Stock Analytics of Peers of ACUTAAS CHEMICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
